Search

Author/Creator Plimack, Elizabeth R.

1. A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma. Issue 14 (5th April 2019)

Authors:
Voss, Martin H.; Bhatt, Rupal S.; Vogelzang, Nicholas J.; Fishman, Mayer; Alter, Robert S.; Rini, Brian I.; Beck, J. Thaddeus; Joshi, Monika; Hauke, Ralph; Atkins, Michael B.; Burgess, Earle; Logan, Theodore F.; Shaffer, David; Parikh, Rahul; Moazzam, Nauman; Zhang, Xiaosha; Glasser, Chad; Sherma...
Journal:
Cancer
Issue:
Volume 125:Issue 14(2019)
Page Start:
2400
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase I Study of Temsirolimus and Bryostatin‐1 in Patients With Metastatic Renal Cell Carcinoma and Soft Tissue Sarcoma. (27th March 2014)

Authors:
Plimack, Elizabeth R.; Tan, Tingting; Wong, Yu‐Ning; Mehren, Margaret M.; Malizzia, Lois; Roethke, Susan K.; Litwin, Samuel; Li, Tianyu; Hudes, Gary R.; Haas, Naomi B.
Journal:
Oncologist
Issue:
Volume 19:Number 4(2014)
Page Start:
354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Phase I Study of Temsirolimus and Bryostatin‐1 in Patients With Metastatic Renal Cell Carcinoma and Soft Tissue Sarcoma. (27th March 2014)

Authors:
Plimack, Elizabeth R.; Tan, Tingting; Wong, Yu‐Ning; von Mehren, Margaret M.; Malizzia, Lois; Roethke, Susan K.; Litwin, Samuel; Li, Tianyu; Hudes, Gary R.; Haas, Naomi B.
Journal:
Oncologist
Issue:
Volume 19:Number 4(2014)
Page Start:
354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma. (18th December 2015)

Authors:
Geynisman, Daniel M.; Handorf, Elizabeth; Wong, Yu‐Ning; Doyle, Jamie; Plimack, Elizabeth R.; Horwitz, Eric M.; Canter, Daniel J.; Uzzo, Robert G.; Kutikov, Alexander; Smaldone, Marc C.
Journal:
Cancer medicine
Issue:
Volume 5:Number 2(2016:Feb.)
Page Start:
192
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Association between baseline body mass index and survival in men with metastatic hormone‐sensitive prostate cancer: ECOG‐ACRIN CHAARTED E3805. Issue 12 (10th May 2022)

Authors:
Morgans, Alicia K.; Chen, Yu‐Hui; Jarrard, David F.; Carducci, Michael; Liu, Glenn; Eisenberger, Mario; Plimack, Elizabeth R.; Bryce, Alan; Garcia, Jorge A.; Dreicer, Robert; Vogelzang, Nicholas J.; Picus, Joel; Shevrin, Daniel; Hussain, Maha; DiPaola, Robert S.; Cella, David; Sweeney, Christophe...
Journal:
Prostate
Issue:
Volume 82:Issue 12(2022)
Page Start:
1176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial. (March 2021)

Authors:
Atkins, Michael B.; Plimack, Elizabeth R.; Puzanov, Igor; Fishman, Mayer N.; McDermott, David F.; Cho, Daniel C.; Vaishampayan, Ulka; George, Saby; Tarazi, Jamal C.; Duggan, William; Perini, Rodolfo; Thakur, Mahgull; Fernandez, Kathrine C.; Choueiri, Toni K.
Journal:
European journal of cancer
Issue:
Volume 145(2021)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data. Issue 24 (17th October 2022)

Authors:
Joyce, Daniel D.; Wymer, Kevin M.; Sharma, Vidit; Moriarty, James P.; Borah, Bijan J.; Geynisman, Daniel M.; Plimack, Elizabeth R.; Costello, Brian A.; Pagliaro, Lance C.; Boorjian, Stephen A.
Journal:
Cancer
Issue:
Volume 128:Issue 24(2022)
Page Start:
4194
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma. Issue 11 (5th April 2022)

Authors:
Motzer, Robert J.; McDermott, David F.; Escudier, Bernard; Burotto, Mauricio; Choueiri, Toni K.; Hammers, Hans J.; Barthélémy, Philippe; Plimack, Elizabeth R.; Porta, Camillo; George, Saby; Powles, Thomas; Donskov, Frede; Gurney, Howard; Kollmannsberger, Christian K.; Grimm, Marc‐Oliver; Barrios,...
Journal:
Cancer
Issue:
Volume 128:Issue 11(2022)
Page Start:
2085
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗